LIFESTANCE HEALTH GROUP INC (LFST) Stock Analyst Ratings
USA - NASDAQ:LFST - US53228F1012 - Common Stock
6.29 USD
+0.04 (+0.64%)
6.35 USD
+0.06 (+0.95%)
ChartMill assigns a Buy % Consensus number of 84% to LFST. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 8.5. This target is 35.13% above the current price.
LFST was analyzed by 14 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about LFST.
In the previous month the buy percentage consensus was at a similar level.
LFST was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-07 | UBS | Maintains | Buy -> Buy |
| 2025-11-06 | BTIG | Maintains | Buy -> Buy |
| 2025-08-08 | UBS | Maintains | Buy -> Buy |
| 2025-05-27 | UBS | Upgrade | Neutral -> Buy |
| 2025-04-08 | Keybanc | Initiate | Overweight |
| 2025-04-03 | Canaccord Genuity | Initiate | Buy |
| 2024-12-16 | Goldman Sachs | Upgrade | Neutral -> Buy |
| 2024-11-11 | Barclays | Maintains | Underweight -> Underweight |
| 2024-08-15 | UBS | Maintains | Neutral -> Neutral |
| 2024-08-09 | Barclays | Maintains | Underweight -> Underweight |
| 2024-04-22 | Morgan Stanley | Reiterate | Overweight -> Overweight |
| 2024-03-06 | Jefferies | Maintains | Buy -> Buy |
| 2024-03-04 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-02-29 | Barclays | Maintains | Underweight -> Underweight |
| 2023-11-22 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2023-11-17 | JP Morgan | Maintains | Neutral -> Neutral |
| 2023-08-10 | JP Morgan | Maintains | Neutral -> Neutral |
| 2023-07-13 | Morgan Stanley | Reiterate | Overweight -> Overweight |
| 2023-05-19 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2023-05-11 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-01-06 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
| 2022-11-15 | Goldman Sachs | Maintains | Neutral |
| 2022-11-14 | Cowen & Co. | Maintains | Outperform |
| 2022-08-22 | Cowen & Co. | Maintains | Outperform |
| 2022-05-10 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-12-17 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-11-09 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2021-09-10 | Cowen & Co. | Initiate | Outperform |
| 2021-08-16 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2021-07-06 | William Blair | Initiate | Outperform |
LIFESTANCE HEALTH GROUP INC / LFST FAQ
Can you provide the average price target for LIFESTANCE HEALTH GROUP INC stock?
14 analysts have analysed LFST and the average price target is 8.5 USD. This implies a price increase of 35.13% is expected in the next year compared to the current price of 6.29.
What is the consensus rating for LIFESTANCE HEALTH GROUP INC (LFST) stock?
The consensus rating for LIFESTANCE HEALTH GROUP INC (LFST) is 84.2857 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed LIFESTANCE HEALTH GROUP INC (LFST)?
The number of analysts covering LIFESTANCE HEALTH GROUP INC (LFST) is 14.